T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model

Anastasiya Slyepchenko; Michael Maes; Cristiano A. Köhler; George Anderson; João Quevedo; Gilberto Sousa Alves; Michael Berk; Brisa S. Fernandes; André F. Carvalho

doi:10.1016/j.neubiorev.2016.02.002

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2024

T cell activation and deficits in T regulatory cells are associated with major depressive disorder and severity of depression

Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, Atapol Sughondhabirom, Michael Maes

Preprint2023

T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviors

Abbas F. Almulla, Ali Abbas Abo Algon, Chavit Tunvirachaisakul, Hussein Kadhem Al‐Hakeim, Michael Maes

Article2023

T helper-1 activation via interleukin-16 is a key phenomenon in the acute phase of severe, first-episode major depressive disorder and suicidal behaviors

Abbas F. Almulla, Ali Abbas Abo Algon, Chavit Tunvirachaisakul, Hussein Kadhem Al‐Hakeim, Michael Maes

Article2023

Role of trazodone in treatment of major depressive disorder: an update

Andrea Fagiolini, Ana González‐Pinto, Kamilla Woznica Miskowiak, Pedro Morgado, Allan H. Young, Eduard Vieta

Article2016

Commensal-Specific CD4+ Cells From Patients With Crohn’s Disease Have a T-Helper 17 Inflammatory Profile

Elisabeth Calderón–Gómez, Helena Bassolas-Molina, Rut Mora‐Buch, Isabella Dotti, Núria Planell, Manel Esteller, Marta Gallego, Mercè Martı́, Carme Garcia-Martín, Carlos Martínez-Torró, Íngrid Ordás, Sharat Singh, Julián Panés, Daniel Benítez‐Ribas, Azucena Salas